A comparative study of the effects of tissue plasminogen activator and dual antiplatelet therapy on improvement of the score of the National Institutes of Health Stroke Scale in acute ischemic stroke treatment.
Phase of Trial: Phase II
Latest Information Update: 22 Dec 2017
At a glance
- Drugs Reteplase (Primary) ; Aspirin; Clopidogrel
- Indications Stroke
- Focus Therapeutic Use
- 19 Dec 2017 New trial record